Seemant Chaturvedi/LinkedIn
Sep 6, 2025, 13:18
Seemant Chaturvedi: Will Tirofiban Benefit Patients with Acute Ischemic Stroke?
NEJM Journal Watch shared on X:
”Tirofiban as Thrombolysis Adjunct for Patients with Acute Ischemic Stroke
Patients might have benefited from tirofiban, although these findings require confirmation before clinicians change their practice.”
Read the full review here.
Article: Tirofiban as Thrombolysis Adjunct for Patients with Acute Ischemic Stroke
Author: Seemant Chaturvedi
Stay informed on all science in the field of thrombosis with Hemostasis Today.
-
May 11, 2026, 16:52Luke McLaughlin: Raising Awareness on Haemophilia Issues at ENIL Lead On
-
May 11, 2026, 16:49Jeff Sternlicht: Normal LDL Does Not Always Mean Low Risk
-
May 11, 2026, 16:42Archil Jaliashvili: From Managing Blood to Managing Oxygen Metabolism
-
May 11, 2026, 16:42Heghine Khachatryan: Celebrating One Hundred Years of von Willebrand Disease with EHC
-
May 11, 2026, 16:34Jane Hankins: Excited to Have Been a Part of the Faculty of ASH CRTI LA
-
May 11, 2026, 16:28Conan McIlwrath at the Rare Bleeding Disorders Conference Representing The Haemophilia Society as Chair
-
May 11, 2026, 16:24Anna A. Avagyan: Presenting Armenia’s Experience at SIOP Europe 2026
-
May 11, 2026, 16:18Mohamed Elkhider: Raising Awareness on Aortic Dissection
-
May 11, 2026, 16:11David McIntosh: A Pensioner’s Reflections on Blood Donation